Protein tyrosine phosphatase inhibition down-regulates ligand-induced ABCA1 expression

Winnie Luu1, Laura J Sharpe, Andrew J Brown

  • 1School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Sydney, NSW 2052, Australia.

Atherosclerosis
|April 16, 2013
PubMed
Abstract

Insights

Inhibition of protein tyrosine phosphatases reduces ATP-binding cassette transporter A1 (ABCA1) expression. This finding reveals a new regulatory mechanism for ABCA1, a key protein in cholesterol homeostasis and atherosclerosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • ATP-binding cassette transporter A1 (ABCA1) is crucial for cellular cholesterol homeostasis and atherosclerosis.
  • ABCA1 facilitates cholesterol export from cells, making it a key lipid transporter.
  • While kinase regulation of ABCA1 is studied, the role of dephosphorylation remains largely unknown.

Purpose of the Study:

  • To investigate the involvement of phosphatases in regulating ABCA1 expression.
  • To explore potential dephosphorylation events controlling ABCA1 levels.

Main Methods:

  • Utilized general protein tyrosine phosphatase inhibitors.
  • Assessed ABCA1 protein and mRNA levels upon stimulation with synthetic ligands.
  • Investigated the role of the nuclear receptor retinoid X receptor (RXR).

Main Results:

  • General protein tyrosine phosphatase inhibitors significantly reduced ABCA1 protein and mRNA.
  • The observed effect on ABCA1 expression was transcriptional.
  • Evidence suggests the involvement of retinoid X receptor (RXR) in this regulation.

Conclusions:

  • Inhibition of protein tyrosine phosphatases leads to down-regulation of ABCA1 expression.
  • This study identifies a novel regulatory pathway for ABCA1.
  • Dephosphorylation represents a new layer of control for this critical cholesterol export protein.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: